During the past decade, Fort Wayne Medical Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fort Wayne Medical Institute" #1 collaborator was "Atlantic Research Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Fort Wayne Medical Institute" are "Asthma" (1 trials), "Diffuse Large B-cell Lymphoma" (1 trials), "Primary Immunodeficiency" (1 trials) and "Relapsed or Refractory Follicular Lymphoma" (1 trials). Many other conditions were trialed in "Fort Wayne Medical Institute" in a lesser frequency.

Most popular intervention types in "Fort Wayne Medical Institute" are "Biological" (2 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "IMA-638" (1 trials), "Immune Globulin Intravenous" (1 trials), "Lenalidomide" (1 trials), "Mosunetuzumab" (1 trials) and "Mosunetuzumab Intravenous (IV)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fort Wayne Medical Institute" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Fort Wayne Medical Institute". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Fort Wayne Medical Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fort Wayne Medical Institute, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".